Genzyme launches Sepracoat in UK:
This article was originally published in Clinica
Genzyme launched its Sepracoat liquid barrier in the UK last week. Sepracoat is used during surgery to coat tissue and protect it from incidental trauma caused by drying, handling and contact with surgical instruments and materials. The viscous coating is made from a concentrated solution of hyaluronic acid, a substance which occurs naturally in the body. Sepracoat remains at the site of surgery for about 24 hours and is resorbed by the body in about five days. Genzyme, based in Cambridge, Massachusetts, is selling Sepracoat as an accompaniment to its Seprafilm physical barrier which is placed between tissues and organs after surgery to avoid adhesions.